Saturday 17 October 2026 Export ARQT’s income statement to Excel — free account

Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $376.1 million, up 91.3% from fiscal 2024. In the quarter to June 2026, revenue grew 59.3%, EPS grew 184.6%, free cash flow grew 228.0% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

28.82 0.28 −0.96%

Follow ARQT

Alert me

Market cap: $3.7B
P/E: 131×
Fwd P/E: 196×
Dividend yield: —
F-score: 4/9
Altman Z: 6.98
Beneish M: −1.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	119.18	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	7.38	7.33	9.82	7.57
P/FCF ratio Full definition →	142.16	269.53	0.00	0.00
P/Operating CF Full definition →	270.77	1,361.25	141.11	(1,371.55)
P/B ratio Full definition →	15.52	16.07	19.50	15.22
Price to Tangible BV Full definition →	16.54	17.38	21.15	16.86
EV/Sales Full definition →	7.10	7.06	9.53	7.31
EV/EBITDA Full definition →	92.59	724.90	0.00	0.00
EV/Operating CF Full definition →	83.76	108.65	(636.90)	(71.34)
EV/FCF Full definition →	136.76	259.37	(168.11)	(48.15)
Quick Ratio Full definition →	2.46	2.26	2.83	3.07
Current Ratio Full definition →	2.92	2.68	3.17	3.50
Net Debt/EBITDA Full definition →	(7.75)	13.19	(5.92)	(9.71)
Debt/Assets Full definition →	22.29%	23.79%	25.17%	29.25%
Debt/Equity Full definition →	0.49	0.58	0.58	0.69
Asset Turnover Full definition →	1.10	1.03	0.96	0.79
Operating CF/Net income Full definition →	0.84	(0.20)	1.51	(0.24)
Capex/Depreciation Full definition →	(0.46)	0.00	0.00	0.00
Interest Coverage Full definition →	4.82	(2.08)	6.13	2.78
Research and Development Expense of Revenue Full definition →	15.67%	29.06%	15.79%	19.76%
Selling, General and Administrative Expense of Revenue Full definition →	63.25%	70.28%	60.98%	62.90%
Intangible Assets out of Total Assets Full definition →	0.03	0.03	0.03	0.04
Share Based Compensation of Revenue Full definition →	9.83%	10.14%	7.77%	10.12%
Graham Net Nets Full definition →	0.06	0.06	0.05	0.06
Graham Number Full definition →	2.89	0.00	0.00	0.00
Earnings Yield Full definition →	0.84%	(0.08%)	(0.45%)	(1.91%)
Free Cash Flow Yield Full definition →	0.70%	0.37%	(0.58%)	(2.01%)
Revenue per Share Full definition →	0.99	0.81	1.02	0.78
Operating CF per Share Full definition →	0.10	0.02	0.21	(0.01)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	0.10	0.02	0.21	(0.01)
Cash per Share Full definition →	1.83	1.73	1.74	1.50
Shareholders Equity per Share Full definition →	1.69	1.47	1.49	1.24
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	1.69	1.47	1.49	1.24
Free Cash Flow Full definition →	12.48	2.24	26.19	(1.75)
Working Capital Full definition →	307.33	274.85	281.39	249.45
Capital Expenditures Full definition →	(0.16)	—	0.00	0.00
Net Current Asset Value Full definition →	199.71	167.70	167.74	136.32
EV/EBIT Full definition →	96.12	912.84	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	99.91	948.60	0.00	0.00
Other line items
Average Receivables Full definition →	130.93	114.90	109.65	87.62
Average Payables Full definition →	10.84	21.41	13.37	12.56
Average Inventory Full definition →	27.60	27.00	18.58	18.22
Average Assets Full definition →	420.49	402.05	390.93	404.17
Average Common Equity Full definition →	179.78	166.15	173.51	157.36

Fold the line items

Columns are period end dates

Stockrow Weekly